COMPANY
FDA-cleared device company
Profile checked Oct 10, 2026
Keywords: Pressure Injury Prevention CLP and pulsation Maxi Move 5
Timeline
- Trial start Not phased (device or behavioral study): A Trial to Investigate the New Caulis Pro® Low Air Loss (LAL) System source ↗
- Trial start Not phased (device or behavioral study): A Comparison Study of the Maxi Move 5 (MM5) Device source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT07213739 | A Trial to Investigate the New Caulis Pro® Low Air Loss (LAL) System | Not phased (device or behavioral study) | Not yet recruiting | Sep 30, 2025 | Mar 30, 2026 (estimated) |
| NCT06173635 | A Comparison Study of the Maxi Move 5 (MM5) Device | Not phased (device or behavioral study) | Completed | Dec 20, 2023 | Feb 28, 2024 (actual) |
